Mandate

Vinge has advised CTEK in connection with its rights issue  

Vinge has advised CTEK AB (publ) on a fully guaranteed rights issue, which will provide CTEK with issue proceeds of approximately SEK 350 million before deduction of transaction costs.

The new shares issued by reason of the rights issue are expected to be admitted to trading on Nasdaq Stockholm on or around 4 April 2023.

CTEK is one of the leading global suppliers of battery chargers for various premium segment vehicles and one of Sweden’s largest suppliers of chargers and accessories for electric vehicle charging. The company is defined by a strong innovation culture and works continuously to improve and develop new products to suit customer needs. CTEK was founded in 1997 in Vikmanshyttan and has sales in over 70 countries. With a history of innovation and technology leadership, the company proactively meets new customer needs by continuously evolving its product range and operations. Through its technology leadership, CTEK has established strong, long-standing customer relationships with over 50 of the world’s most prestigious vehicle manufacturers. In addition to vehicle manufacturers, CTEK offers products to vehicle repair shops, distributors, retailers, charging point operators and property owners, among others.

Vinge’s team consisted primarily of David AnderssonWilliam KågeOskar NilssonLorin Arabi and Gabriel Chabo (Capital Markets and Public M&A), Eléonore Friberg and Ebba Nyberg (M&A).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025